BCRX
BioCryst Pharmaceuticals Inc
8.20$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.7% | 74.3% | 78.7% | 33.5% | 36.4% | 54.8% | 60.4% | 68.8% | 73.5% | 81.7% | 66.9% | 64.3% | 88.6% | 78.1% | 88.4% | 77.3% | 73.1% | 86.2% | 65.3% | 53.0% | 74.6% | 70.3% | 77.9% | 93.8% | 96.7% | 96.3% | 93.9% | 95.9% | 86.0% | 78.6% | |
| 9.7% | 14.3% | 42.3% | 11.7% | 11.9% | 31.9% | 33.5% | 39.7% | 27.2% | 29.4% | 6.5% | 21.8% | 26.4% | 28.9% | 12.3% | 20.0% | 36.4% | 43.3% | 39.8% | 23.2% | 24.6% | 28.2% | 18.2% | 65.1% | 81.3% | 85.8% | 55.4% | 21.4% | 21.4% | 17.5% | |
| 9.7% | 14.3% | 42.3% | 31.5% | 34.8% | 54.1% | 59.2% | 66.5% | 71.4% | 50.6% | 54.7% | 35.5% | 72.6% | 48.5% | 48.8% | 50.7% | 64.0% | 83.2% | 83.2% | 79.7% | 70.8% | 87.3% | 86.4% | 77.7% | 89.7% | 86.3% | 77.1% | 75.2% | 65.5% | 53.4% | |
| – | – | – | – | – | – | – | – | – | 30.2% | 6.7% | 27.4% | 14.1% | 23.7% | 27.3% | 9.2% | 7.9% | 4.3% | 6.9% | 5.0% | 9.8% | 3.4% | 2.9% | 12.6% | 2.6% | 5.0% | 9.2% | 11.0% | 16.1% | 20.8% | |
| – | – | – | – | – | – | – | – | – | -52,335.8% | -12,160.8% | -28,731.9% | -15,934.0% | 4.4% | 0.8% | 0.3% | -0.8% | -4.8% | 0.5% | 1.3% | 0.6% | -21.2% | 1.1% | 0.9% | 2.1% | 2.7% | 5.0% | 5.5% | 1.6% | 1.0% | |
| – | – | – | – | 5.4% | 9.1% | 11.0% | 11.7% | 8.7% | 2.4% | 4.4% | 3.7% | 5.8% | 2.7% | 1.7% | 1.3% | 1.0% | 0.6% | 0.2% | 4.1% | 11.0% | 5.4% | 6.2% | 4.2% | 2.1% | 2.6% | 2.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 0.4% | 0.3% | 0.3% | 0.4% | 0.6% | 0.2% | 0.6% | 0.8% | 0.2% | 0.4% | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 4.6% | 4.5% | 4.8% | 2.7% | 13.2% | 3.9% | 2.8% | 5.5% | 9.7% | 41.1% | 69.1% | 54.5% | 45.2% | 39.3% | 39.7% | 82.0% | 100.8% | 102.3% | 44.7% | 61.7% | 98.2% | 53.0% | 66.5% | 78.2% | 105.8% | 118.2% | 153.6% | 188.1% | 197.0% | 123.2% | |
| 3.8% | 3.4% | 3.8% | 2.3% | 5.8% | 3.4% | 2.1% | 4.5% | 8.7% | 11.5% | 15.7% | 19.7% | 20.2% | 26.2% | 25.2% | 14.9% | 30.0% | 31.2% | 42.1% | 51.7% | 60.5% | 42.0% | 47.3% | 52.7% | 31.6% | 17.6% | 19.2% | 29.0% | 32.7% | 38.1% | |
| 0.5% | 0.4% | – | – | 0.0% | 507.6% | 726.4% | 996.8% | 924.0% | – | – | – | 10.9% | – | – | – | – | – | 21.9% | 22.3% | 31.4% | 19.8% | 23.0% | 22.8% | 9.3% | 0.3% | 0.4% | 0.5% | 7.2% | 0.3% | |
| 1.6% | 0.8% | 0.7% | 0.4% | 1.1% | 1.0% | 0.6% | 2.1% | 6.1% | 8.9% | 8.6% | 13.9% | 6.2% | 12.7% | 7.4% | 3.0% | 6.9% | 8.5% | 2.1% | 7.5% | 4.8% | 3.6% | 5.3% | 8.0% | 5.6% | 4.7% | 2.6% | 4.0% | 2.4% | 3.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 36.5% | 52.2% | 61.4% | 0.0% | 1.9% | 25.4% | 9.4% | 17.3% | 23.6% | 35.8% | 99.5% | 133.3% | 156.9% | 162.3% | 83.1% | |
| 95.4% | 95.5% | 95.2% | 97.3% | 86.8% | 96.1% | 97.2% | 94.5% | 90.3% | 58.9% | 30.9% | 45.5% | 54.8% | 60.7% | 60.3% | 18.0% | -683.5% | -865.0% | -341.8% | -410.2% | -630.0% | -354.5% | -498.5% | 21.8% | -5.8% | -18.2% | -53.6% | -88.1% | -97.0% | -23.2% | |
| -101.9% | -182.6% | -182.8% | -79.7% | -98.9% | -127.0% | -222.7% | -347.8% | -387.3% | -153.0% | -285.4% | -157.3% | -294.3% | -184.8% | -267.2% | -430.0% | -683.5% | -865.0% | -341.8% | -410.2% | -630.0% | -354.5% | -498.5% | -479.6% | -305.8% | -205.3% | -264.5% | -325.2% | -360.9% | -292.9% | |
| 30.1% | 52.0% | 48.5% | 21.0% | 26.8% | 29.7% | 42.7% | 58.8% | 65.2% | 25.9% | 42.6% | 23.0% | 44.9% | 27.4% | 40.3% | 54.9% | 86.1% | 113.0% | 48.8% | 58.5% | 82.0% | 47.4% | 70.3% | 66.0% | 50.0% | 30.5% | 33.8% | 37.2% | 42.1% | 42.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.